Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).

Patients with terminal renal insufficiency suffer from an increased incidence of atherosclerotic diseases. Elevated plasma concentrations of lipoprotein(a) [Lp(a)] have been established as a genetically controlled risk factor for these diseases. Variable alleles at the apo(a) gene locus determine to...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Dieplinger, H, Lackner, C, Kronenberg, F, Sandholzer, C, Lhotta, K, Hoppichler, F, Graf, H, König, P
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1993
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC287937/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8432847/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116213
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!